Kier’s share price is down 93% in 3 years. Here’s my view on the stock now

Kier shares have experienced a terrible run over the last three years, losing more than 90% of their value. But it could be turning things around.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The last time I covered Kier (LSE: KIE) shares was in mid-June 2019. At the time, the stock looked cheap. However, it was clear the company had some serious challenges to work through. As a result, I said the best move was to avoid the stock.

Fast forward to today. Kier’s share price is now nearly 30% lower than it was in mid-June last year. So, avoiding the stock was definitely the right move. Has the outlook for Kier improved since my last article? Let’s take another look at the investment case.

Kier shares: an encouraging trading update

Kier’s most recent trading update, issued on 1 July, was relatively encouraging, in my view. While the company said Covid-19 had adversely affected the group’s revenue and resulted in additional costs, it also said its underlying performance recently had “remained resilient.”

It added that due to the strength of the group’s orderbook (£7.6bn at 31 May), its expertise in managing complex projects, and its long-standing client relationships, it remained confident in its outlook for the financial year ending 30 June 2021.

This update suggests to me that since my article, Kier has made some progress in terms of turning things around.

Insiders have been buying

It’s also encouraging to see that some insiders have purchased Kier shares in recent months. Back in March, they included CEO Andrew Davies, CFO Simon Kesterston, and chairman Matthew Lester buying KIE shares. While the purchases weren’t huge, I still see this kind of insider transaction activity as relatively bullish.

The shorters have backed off

It’s also worth noting that shorters (hedge funds betting against Kier shares) have really backed off recently. Back in 2018, Kier was one of the most shorted stocks on the LSE. For example, in September 2018, short interest was a worryingly high 18%, suggesting that many hedge funds were expecting the stock to fall. Today though, short interest is just 1.2%, according to shorttracker.co.uk. This indicates the outlook for Kier has improved.

Red flags

However, there are still some red flags here. One is the company’s debt level. In its most recent trading update, the group advised its average month-end net debt for the current financial year is expected to be approximately £440m. Given that equity on the balance sheet at 31 December was £519m, that’s quite high. Having a high level of debt in the current economic environment isn’t ideal.

Another red flag is that brokers continue to downgrade their earnings forecasts. Over the last three months, the consensus earnings per share forecast for this year has fallen about 10%.

Kier share price: my view

Weighing everything up, I’m starting to see some appeal in Kier shares. The valuation is low (forward P/E ratio of just 2.1) and the company looks to be turning things around.

I wouldn’t buy the stock myself, as I prefer to invest in high-quality businesses that are highly profitable and very resilient. However, as a turnaround play, I do think the stock is starting to look interesting.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »